Today's episode on Redefining Medicine features Alex Zhavoronkov, PhD. As CEO of Insilico Medicine, Zhavoronkov is a pioneer in artificial intelligence, deep learning techniques, and blockchain technologies for drug discovery and biomarker development. With a long-held belief that the issue of aging needs to be further researched and addressed, Zhavoronkov seeks to discover how precision medicine can further advance treatment protocols for patients. Through research focuses on genomics, epigenetics, and personalized screening techniques, Zhavoronkov works on advancing Regenerative and Anti-Aging Medicine with the most cutting-edge technologies and clinical research.